Production of PfEMP1-specific human monoclonal antibodies from naturally immune individuals
Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review
Standard
Production of PfEMP1-specific human monoclonal antibodies from naturally immune individuals. / Walker, Melanie R; Barfod, Lea.
Malaria Immunology: Targeting the Surface of Infected Erythrocytes. Vol. 2470 Humana Press, 2022. p. 407-421 (Methods in molecular biology (Clifton, N.J.)).Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - CHAP
T1 - Production of PfEMP1-specific human monoclonal antibodies from naturally immune individuals
AU - Walker, Melanie R
AU - Barfod, Lea
N1 - © 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2022
Y1 - 2022
N2 - Plasmodium falciparum parasites express variable surface antigens on the infected erythrocyte surface allowing adhesion to human host receptors on the blood and endothelial cells, which can result in immune evasion. One of the most studied and key antigens in adhesion is the highly polymorphic PfEMP1. However, despite the vast variation in the PfEMP1 antigens, they are the main targets of naturally acquired immunity and are therefore promising candidates for malaria vaccine development. Generating PfEMP1-specific human monoclonal antibodies from naturally immune individuals will help to determine the best targets of protection from clinical disease. Immortalization of human B cells is one of the oldest and most efficient techniques to generate human monoclonal antibodies. Nevertheless, most protocols require flow cytometry-based cell sorting, which can be a limiting factor for many laboratories. This chapter describes an efficient protocol for the generation of PfEMP1-specific human monoclonal antibodies from malaria immune individuals that can be performed without the use of advanced cell-sorting techniques.
AB - Plasmodium falciparum parasites express variable surface antigens on the infected erythrocyte surface allowing adhesion to human host receptors on the blood and endothelial cells, which can result in immune evasion. One of the most studied and key antigens in adhesion is the highly polymorphic PfEMP1. However, despite the vast variation in the PfEMP1 antigens, they are the main targets of naturally acquired immunity and are therefore promising candidates for malaria vaccine development. Generating PfEMP1-specific human monoclonal antibodies from naturally immune individuals will help to determine the best targets of protection from clinical disease. Immortalization of human B cells is one of the oldest and most efficient techniques to generate human monoclonal antibodies. Nevertheless, most protocols require flow cytometry-based cell sorting, which can be a limiting factor for many laboratories. This chapter describes an efficient protocol for the generation of PfEMP1-specific human monoclonal antibodies from malaria immune individuals that can be performed without the use of advanced cell-sorting techniques.
KW - Antibodies, Monoclonal
KW - Antibodies, Protozoan
KW - Antigens, Protozoan
KW - Endothelial Cells
KW - Erythrocytes/parasitology
KW - Humans
KW - Malaria
KW - Malaria, Falciparum/parasitology
KW - Plasmodium falciparum
KW - Protozoan Proteins
U2 - 10.1007/978-1-0716-2189-9_30
DO - 10.1007/978-1-0716-2189-9_30
M3 - Book chapter
C2 - 35881362
VL - 2470
T3 - Methods in molecular biology (Clifton, N.J.)
SP - 407
EP - 421
BT - Malaria Immunology
PB - Humana Press
ER -
ID: 320649209